Similar to our findings, a recent meta-analysis demonstrated that high expression of CXCR7 is associated with higher risk of lymph node metastasis (LNM), higher tumor grade, poorer overall survival (OS), and shorter recurrence-free survival, across multiple cancer types14. This evidence concerns the gene ACKR3 and metastatic malignant neoplasm in the lymph nodes.